FRMSL (4746.TW) monthly revenue, September 2026
FRMSL reported revenue of NT$0.49bn for September 2026, up 6.3% from the previous month and up 17.2% from a year earlier. Year-to-date revenue was NT$3.51bn, down 1.0% year on year. It ranked 60 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.49 | 6.3 | 17.2 |